Meddoc AS   Report issue

Academic/Hospital Phase 2
Founded: Gibraltar United Kingdom (2015)

Organization Overview

First Clinical Trial
2015
NCT04298333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Meddoc | Meddoc AS | Meddoc Research Indonesia Ltd | Meddoc Research Taiwan Ltd

Active Ingredients

Drugs in Phase 2 Trials (2)

bp-c1 (5 trials)

bp-c2 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 2